-
-
10-2021 Guidance document VOV art 39b gm-cells LV-RV 14-10-2021 10-2021 Guidance document VOV art 39b gm-cells LV-RV PDF | 238.45 kB
-
2020-07-23 Guidance document gm-cells - Netherlands _V1.1 14-10-2021 2020-07-23 Guidance document gm-cells - Netherlands _V1.1 PDF | 286.57 kB
-
Gestandaardiseerde MRB VOV gm cellen zonder viruspartikels 14-10-2021 Gestandaardiseerde MRB VOV gm cellen zonder viruspartikels PDF | 455.4 kB
-
Gestandaardiseerde MRB VOV gm cellen LV met SIN deeltjes 14-10-2021 Gestandaardiseerde MRB VOV gm cellen LV met SIN deeltjes PDF | 529.1 kB
-
10-2021 Guidance document VOV art 39c gm-cells LV-SIN 14-10-2021 10-2021 Guidance document VOV art 39c gm-cells LV-SIN PDF | 237.28 kB
-
Common application form for viral vectors contained in investigational medicinal products for human use 01-11-2019 Common application form for viral vectors contained in investigational medicinal products for human use DOCX | 43.58 kB
-
Good Practice on the assessment of GMO related aspects in the context of clinical trials with AAV clinical vectors 01-11-2019 Good Practice on the assessment of GMO related aspects in the context of clinical trials with AAV clinical vectors PDF | 360.96 kB
-
Common application form for investigational medicinal products for human use that contain or consist of AAV vectors 01-11-2019 Common application form for investigational medicinal products for human use that contain or consist of AAV vectors DOCX | 36.54 kB
-